SEC Form D private-offering filing

Protego Biopharma, Inc.

Name: Protego Biopharma, Inc. - new SEC Form D private-offering filing, San Diego, CA
Published: 2025-12-03

A new SEC Form D private-offering notice from San Diego, CA, a $130,442,180 filer-stated offering target in Biotech. The source filing is one click away.

Protego Biopharma, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing small molecule pharmacological chaperones for AL amyloidosis and other protein misfolding diseases.

Filed 2025-12-03Filed to raise $130,442,180First money in 2025-10-17Raised so far $32,942,190HQ (as filed) San Diego, CASector Biotech ✓Stage (inferred) LateCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified protegobio.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.